Swedish maker of voice prostheses and laryngectomy and tracheostomy care products, best known for the Provox range, founded in 1986 by the brothers Gert and Jan-Ove Persson. Denmark’s Coloplast bought it for an enterprise value of €2,155 million in a deal completed in January 2022. In Portugal a Lisbon branch of its Spanish subsidiary supplies ENT products to public hospitals.
Atos Medical reaches Portuguese patients through a branch of its Spanish subsidiary: Atos Medical Spain, S.L. – Sucursal em Portugal (NIF 980435978), registered in Lisbon (1170-105). The branch bids into the tenders of the Portuguese National Health Service’s local health units. In April 2025 the Unidade Local de Saúde do Alentejo Central in Évora awarded it an ear-nose-and-throat medical-device contract worth €34,190 (TED 389298-2025), and in May 2024 Madeira’s regional health service SESARAM awarded Atos Medical Spain a lot in its ENT-materials procurement (TED 410283-2024), with a Portugal-specific contact address on the notice.
The products behind those contracts are the Provox voice prostheses, heat-and-moisture exchangers and stoma-care accessories used by people who have had their larynx removed, plus tracheostomy products from TRACOE, which Atos bought in 2021 together with Kapitex Healthcare and MC Europe. When Coloplast announced the acquisition in November 2021, Atos had about 1,150 staff, customers in some 90 countries and pro-forma 2020 revenue of SEK 2.2 billion; Coloplast called it the largest acquisition in its history.
Atos Medical is a small-volume, high-value example of Nordic medtech in Portugal: a niche with few patients but lifelong consumable use, served from an Iberian hub rather than a Portuguese company. Under Coloplast ownership it is also part of a Danish group that already runs one of Portugal’s largest Nordic-owned factories, in Felgueiras — so the corridor footprint of the combined group is considerably larger than the Atos branch alone.
April 2025 — ULS Alentejo Central ENT-devices award, €34,190 (TED 389298-2025).
January 2022 — Coloplast completed the €2,155 million acquisition of Atos Medical.
Status: Compiled from public sources · Last verified: · Update this profile
Work at Atos Medical? Send corrections or additions. Every update is checked before it is published; submissions are reviewed within a few working days.
Fractio helps Nordic companies enter the Portuguese market — from market sizing to first sales, hiring, and legal setup.
Talk to Fractio →